- Investing Ideas
- /
- Danish Pharmaceuticals & Biotech High Growth Potential Companies
Danish Pharmaceuticals & Biotech High Growth Potential Companies
Results
4
Companies with a Future performance score of at least 3, ordered by Future performance score.
4 companies
Novo Nordisk
Market Cap: DKK 1.6t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
NOVO B
DKK 358.80
7D
-1.4%
1Y
-61.8%
ChemoMetec
Market Cap: DKK 9.1b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 521.00
7D
-1.0%
1Y
39.1%
Genmab
Market Cap: DKK 97.7b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,588.00
7D
1.1%
1Y
-15.2%
ALK-Abelló
Market Cap: DKK 44.5b
Operates as an allergy solutions company in Europe, North America, and internationally.
ALK B
DKK 201.20
7D
-3.7%
1Y
12.4%